CRISPR Therapeutics AG
NASDAQ: CRSP
$55.89
Closing price May 3, 2024
CRSP Articles
Tuesday's top analyst upgrades and downgrades included ADM, Beyond Meat, Bristol-Myers, Carvana, CRISPR, FirstEnergy, Peloton, Shopify, Tesla, Uber and Visa.
Published:
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Published: